Norway vs Sri Lanka: Previously treated cases tested for RR-/MDR-TB
Norway
100.0%
in 2024
Sri Lanka
100.0%
in 2024
Norway rank
1st
Sri Lanka rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Norway
- Sri Lanka
How they compare
Norway currently reports 100.0% against 100.0% in Sri Lanka, a difference of 0.0%.
The two have swapped places 4 times across 19 shared years of data; in 2005 it was Sri Lanka ahead.
Norway ranks 1st and Sri Lanka ranks 1st of 180 countries.
Across the 3 decades both report, Norway averaged higher in 1 and Sri Lanka in 2.
Head to head by decade
| Decade | Norway | Sri Lanka | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 60.0% | 86.0% | 26.0% | Sri Lanka |
| 2010s | 62.5% | 85.6% | 23.1% | Sri Lanka |
| 2020s | 89.2% | 81.5% | 7.8% | Norway |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Norway or Sri Lanka?
- Norway, at 100.0% against 100.0% in Sri Lanka as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Norway and Sri Lanka?
- 0.0%, with Norway ahead.
- How many years of comparable data are there for Norway and Sri Lanka?
- 19 years are reported by both, from 2005 to 2024.
- How do Norway and Sri Lanka rank globally for previously treated cases tested for rr-/mdr-tb?
- Norway ranks 1st and Sri Lanka ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.